Effects of the WHO Labour Care Guide on cesarean section in India: a pragmatic, stepped-wedge, cluster-randomized pilot trial

Author:

Vogel Joshua P.ORCID,Pujar Yeshita,Vernekar Sunil S.ORCID,Armari Elizabeth,Pingray Veronica,Althabe Fernando,Gibbons LuzORCID,Berrueta Mabel,Somannavar ManjunathORCID,Ciganda Alvaro,Rodriguez Rocio,Bendigeri Savitri,Kumar Jayashree Ashok,Patil Shruti Bhavi,Karinagannanavar Aravind,Anteen Raveendra R.,Mallappa Ramachandrappa Pavithra,Shetty Shukla,Bommanal Latha,Haralahalli Mallesh Megha,Gaddi Suman S.,Chikkagowdra Shaila,Raghavendra Bellara,Homer Caroline S. E.ORCID,Lavender Tina,Kushtagi Pralhad,Hofmeyr G. JustusORCID,Derman Richard,Goudar ShivaprasadORCID

Abstract

AbstractCesarean section rates worldwide are rising, driven by medically unnecessary cesarean use. The new World Health Organization Labour Care Guide (LCG) aims to improve the quality of care for women during labor and childbirth. Using the LCG might reduce overuse of cesarean; however, its effects have not been evaluated in randomized trials. We conducted a stepped-wedge, cluster-randomized pilot trial in four hospitals in India to evaluate the implementation of an LCG strategy intervention, compared with routine care. We performed this trial to pilot the intervention and obtain preliminary effectiveness data, informing future research. Eligible clusters were four hospitals with >4,000 births annually and cesarean rates ≥30%. Eligible women were those giving birth at ≥20 weeks’ gestation. One hospital transitioned to intervention every 2 months, according to a random sequence. The primary outcome was the cesarean rate among women in Robson Group 1 (that is, those who were nulliparous and gave birth to a singleton, term pregnancy in cephalic presentation and in spontaneous labor). A total of 26,331 participants gave birth. A 5.5% crude absolute reduction in the primary outcome was observed (45.2% versus 39.7%; relative risk 0.85, 95% confidence interval 0.54–1.33). Maternal process-of-care outcomes were not significantly different, though labor augmentation with oxytocin was 18.0% lower with the LCG strategy. No differences were observed for other health outcomes or women’s birth experiences. These findings can guide future definitive effectiveness trials, particularly in settings where urgent reversal of rising cesarean section rates is needed. Clinical Trials Registry India number: CTRI/2021/01/030695.

Funder

Bill and Melinda Gates Foundation

Department of Health | National Health and Medical Research Council

Burnet Institute

Bill and Melinda Gates Institute for Population and Reproductive Health

Publisher

Springer Science and Business Media LLC

Reference45 articles.

1. WHO, UNICEF, UNFPA, World Bank & UNDP. Trends in Maternal Mortality 2000 to 2020 (World Health Organization, 2023).

2. United Nations Inter-Agency Group for Child Mortality Estimation. Levels and Trends in Child Mortality (UNICEF, 2022).

3. Hug, L. et al. Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment. Lancet 398, 772–785 (2021).

4. Alliance for Maternal Newborn Health Improvement Mortality Study Group. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. Lancet Glob. Health 6, e1297–e1308 (2018).

5. The Global Strategy for Women’s, Children’s and Adolescents’ Health (World Health Organization, 2017).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3